跳至主要内容
临床试验/NCT01527292
NCT01527292终止不适用

Randomized Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

University of Louisville2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2012年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
2
主要终点
Numerical Rating Pain Scale (NRPS) Change in Patients

研究概览

简要总结

The purpose of this study is to determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months post-treatment.

详细描述

Eligible Vertebral Metastatic Lesion/s-> randomized-> SRT versus SRT+ VAP Stereotactic Radiation Therapy(SRT): 16 Gy X 1 Evaluation: prior to treatment; 1 month, 2-4 months, 5-6 months and 1 year post-treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • ECOG performance status 0-
  • Known histologically proven malignancy.
  • Localized osteolytic spine metastases from T7 to L5 demonstrated by MRI, CT, PET or bone scan: a solitary spine metastasis; two separate spine levels; or up to 3 separate sites (each site may have a maximal involvement of 2 contiguous vertebral bodies with or without a paraspinal mass of no more than 5 cm).
  • Negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential.
  • Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control.
  • Numerical Rating Pain Scale (NRPS) and movement-related pain score(MRPS) within two (2) weeks prior to registration.
  • The patient must have a score of ≥ 5 for at least one of the planned sites for SRT.
  • Patients must provide study specific informed consent prior to study entry.
  • Required Pre-treatment Evaluations: baseline Numerical Rating Pain Scale (NRPS), movement-related pain score, dose and frequency of all pain medications; QOL Measure using the Oswestry Disability Questionnaire, and EuroQOL(EQ-5D).

排除标准

  • Non-ambulatory patients.
  • Frank spinal cord compression or epidural compression within 3 mm of the spinal cord.
  • Osteoblastic vertebral metastasis.
  • Prior radiation to the index spine.
  • Patients with rapid neurologic decline.

研究组 & 干预措施

Control Group

Active Comparator

Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only

干预措施: Stereotactic Radiation Therapy (Radiation)

Treatment Group

Experimental

SRT with Vertebral Augmentation Procedure Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure

干预措施: SRT with Vertebral Augmentation Procedure (Radiation)

结局指标

主要结局

Numerical Rating Pain Scale (NRPS) Change in Patients

时间窗: For 6 months post treatment

To determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s)at 1 month, 2-4 months and 5-6 months post-treatment and to validate of the movement-related pain score

次要结局

  • Vertebra Measurement(For 1 year post treatment)
  • Reduction of Pain Estimate(For 1 year post treatment)
  • Feasibility Rate Estimation(For 1 year post treatment)
  • Toxicity Rate Estimation(For 1 year post treatment)
  • Quality of Life Estimate(For 1 year post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shiao Yuo Woo

Chair-Radiation Oncology

University of Louisville

研究点 (2)

Loading locations...

相似试验